AI
Also, a new research centre at the University of Melbourne will use AI to advance breast cancer screening.
The technology uses heart rate variability measurements to assess the severity of sepsis in ED patients.
SPONSORED
HIMSS22 Europe
![]()
|
05:09 pm |
September 12, 2022
Healthcare institutions will be successful if they unite clinical medicine and data science, says Simon Philip Rost, CMO at GE Healthcare Enterprise Digital Solutions.
The solution screens for plus disease, which is associated with severe ROP.
Individuals are also less likely to trust AI-suggested interventions than those recommended by humans.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
This comes after it launched its CDI tool called DxPrime in June.
According to the World Health Organization, breast cancer survival rates vary significantly between different countries.